NCT02039700View on ClinicalTrials.gov

Bioavailability of Lesinurad and Intravenous [14C]Lesinurad

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

Lesinurad 400 mg

DRUG

[14C]lesinurad (100 μg per 10 mL)

Trial Locations (1)

53704

Madison

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY